Patients (n=80)
Age (years)
55 (25.0-89.0)
FIGO stage
I
10 (12%)
II
31 (39%)
III
28 (35%)
IV
11 (14%)
Histology
Squamous cell ca.
69 (86%)
Adenocarcinoma
11 (14%)
Brachytherapy
Low-dose-rate
79 (99%)
High-dose-rate
1 (1%)
Chemotherapy
37 (47%)
Table 1:
Patient characteristics.
